Stay updated on GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Sign up to get notified when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.

Latest updates to the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check15 days agoChange DetectedA notice was added explaining that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.SummaryDifference0.8%

- Check22 days agoChange DetectedThe site revision label changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedThe ClinicalTrials.gov page footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.7.0 is added to the record history, and the previous v3.6.6 entry is removed. The update reflects changes to the administrative history of the study record.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision entry (v3.6.6) was added to the history and the previous revision (v3.6.5) was removed, updating the record’s version history to reflect the latest revision.SummaryDifference0.1%

Stay in the know with updates to GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.